<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Curierul Medical, 2016, Vol. 59, No 3</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/1131</link>
<description>Materialele Congresului V Naţional de Dermatologie cu participare internaţională Chişinău, 9-11 iunie 2016, Chişinău, Republica Moldova</description>
<pubDate>Fri, 10 Apr 2026 22:08:53 GMT</pubDate>
<dc:date>2026-04-10T22:08:53Z</dc:date>
<item>
<title>Curierul medical. Iunie 2016, Vol. 59, No 3</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/16196</link>
<description>Curierul medical. Iunie 2016, Vol. 59, No 3
From its debut in 1958, the journal has striven to support the interests of&#13;
Moldovan medicine concerning the new concepts of its development. The&#13;
Editorial Board warmly welcomes both the readers of and the authors for the&#13;
journal, all those who are enthusiastic in searching the new and more effective&#13;
ways of solving numerous medical problems. We hope that those who want&#13;
to make their contribution into the science of medicine will find our journal&#13;
helpful and encouraging.&#13;
The journal is accredited by the National Council for Accreditation and&#13;
Attestation. The journal publishes official papers, scientific articles, editorials,&#13;
clinical studies and cases, lectures, methodological guides, reviews, brief reports, and correspondence. The journal welcomes articles in English, Romanian and&#13;
Russian. The journal editorial policy provides the prompt publication of papers&#13;
within 12 weeks after receiving them.; De la prima apariţie în 1958, revista susţine şi dezvoltă noile idei în&#13;
domeniul medicinii, în Republica Moldova. Colegiul de redacţie agrează cu&#13;
multă consideraţie atât cititorii cât şi autorii articolelor, pe toţi acei care cu mult&#13;
entuziasm caută noi şi mult mai efective metode de soluţionare a multiplelor&#13;
probleme ale medicinii. Sperăm, că toţi acei care doresc să-şi aducă aportul&#13;
la dezvoltarea ştiinţelor medicale, vor găsi revista noastră utilă şi atractivă.&#13;
Revista este acreditată de către Consiliul Naţional de Acreditare și Atestare.&#13;
Revista publică comunicări oficiale și, totodată, sunt editate diverse publicaţii,&#13;
inclusiv independente: articole știinţifice, editoriale, cercetări și prezentări de&#13;
cazuri clinice, prelegeri, îndrumări metodice, articole de sinteză, relatări scurte,&#13;
corespondenţe și recenzii. Revista publică articole în limba engleză, română și&#13;
rusă. Politica de editare a revistei prevede examinarea operativă și publicarea&#13;
articolelor timp de 12 săptămâni după înaintare.; С первого дня своего выпуска в 1958 году журнал стремится поддерживать и развивать новые идеи в области медицины в Молдове. Редакционная коллегия всегда рада как читателям, так и авторам статей,&#13;
всем тем, кто с энтузиазмом ищет новые, более эффективные способы&#13;
решения многочисленных задач медицины. Мы надеемся, что все те, кто&#13;
хотят внести свой вклад в медицинскую науку, найдут наш журнал полезным и вдохновляющим.&#13;
Журнал аккредитован Высшей Аттестационной Комиссией Республики Молдова. В журнале печатаются официальные материалы, научные статьи, наблюдения из клинической практики, обобщающие статьи,&#13;
краткие сообщения, методические указания, рецензии и корреспонденция. В журнале публикуются статьи на английском, румынском и русском языках. Издательская политика журнала предусматривает оперативное рассмотрение и публикацию статей в среднем в течение 12 недель после поступления.
Fondatori: Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie “Nicolae Testemiţanu”.&#13;
&#13;
Materialele Congresului V Naţional de Dermatologie cu participare internaţională Chişinău, 9-11 iunie 2016, Chişinău, Republica Moldova
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/16196</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Technologies for in vitro cultivation of skin fibroblasts for patients with chronic ulcers treatment</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/15320</link>
<description>Technologies for in vitro cultivation of skin fibroblasts for patients with chronic ulcers treatment
Malcova, Tatiana; Cirimpei, Diana; Cirimpei, Octavian; Nacu, Viorel
Background: As many factors lead to chronic lower leg ulceration, an interdisciplinary approach to the systematic assessment of the patient is required,&#13;
in order to ascertain the pathogenesis, definitive diagnosis, and optimal treatment.  A number of researchers propose to use in ulcers treatment non&#13;
senescent fibroblasts. By donating additional cells to the wound environment releasing extra growth factors and reversing the antiproliferative activity&#13;
of chronic wound exudates can be achieved.&#13;
Material and methods: The main stages of fibroblasts’ cultivation are: obtaining of skin biopsy, donors’ serologic control, preparing culture flasks,&#13;
separation of epidermis and dermis, proper cultivation, cells bacteriological control and application.&#13;
Results: The final cell density in primary culture was 4,5*104 cells/cm2&#13;
. It’s demonstrated that tissue-engineered human dermal fibroblasts can replace&#13;
the dermis and provide essential stimulatory growth factors for wound healing.&#13;
Conclusions: The overall safety and lack of rejection reactions combined with the efficacy encourage the use of HFDD in addition to good wound&#13;
care practices
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/15320</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Skinboosters – rolul acidului hialuronic în tratamentul cicatricilor postacneice</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/13386</link>
<description>Skinboosters – rolul acidului hialuronic în tratamentul cicatricilor postacneice
Şoşoacă, Ina
În societatea modernă, aspectul fizic joacă un rol extrem de important, atât în viaţa personală, cât şi în cea profesională a&#13;
fiecărui individ. Unul din factorii care influenţează în mod negativ demersul echilibrat al evenimentelor, trăirilor sau experienţelor&#13;
din viaţa noastră, este exprimat de prezenţa cicatricilor postacneice la nivelul chipului, acestea afectând semnificativ calitatea&#13;
vieţii pacienţilor.&#13;
Alegerea metodei de tratament a cicatricilor postacneice se face în funcţie de tipul şi forma acestora, gradul de severitate şi&#13;
culoare, mărimea şi localizarea, dar şi experienţa, tratamentele anterioare, prezenţa sau absenţa inflamaţiei.&#13;
În ceea ce priveşte tratamentul cicatricilor, un mare succes îl are gama Restylane Skinboosters – fillere dermice cu acid&#13;
hialuronic. Acidul hialuronic creşte conţinutul de apă în spaţiul extracelular, reface mediul fiziologic în derm, optimizează&#13;
enzimele şi stimulează metabolismul, dar şi activitatea fibroblaştilor. Are numeroase funcţii, de la redarea elasticităţii pielii&#13;
până la lubrifierea articulaţiilor.
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/13386</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Alogrefele în tumorile osoase benigne</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/13385</link>
<description>Alogrefele în tumorile osoase benigne
Groza, Costina; Dascaliuc, Ion; Topor, Boris
Background: Bone morphogenetic proteins (BMPs) are essential mediators of bone formation involved in the regulation of differentiation of&#13;
osteoprogenitor cells into osteoblasts. By their osteoinductive capacities, BMPs have been considered as the most potent growth factors that can promote&#13;
the bone regeneration and repair, representing an important alternative to bone autotransplant.&#13;
Material and methods: Underlying work is accumulated material within the Department of General Oncology and Rehabilitation Oncology Institute&#13;
of Moldova. There were supervised 572 patients with benign tumors in the period from 2005 to 2015.&#13;
Results: Tests revealed that the most frequent benign tumors are cartilaginous ones: osteocondroms 39 to 2.0 %, condroms 14 to 1.5%, condroblastoms&#13;
– 2 to 0.6%. After cartilaginous tumors, second place is occupied by osteoclastoma. Rarely, patients with bone cyst and osteodisplastic fibrous bone&#13;
lipoma are uncounted. Other processes are rarely encountered. Benign tumors more often prevail at men (58 ± 2%).&#13;
Conclusions: Experimental and clinical studies suggested a great potential of BMPs in bone formation, especially in critical size bone defects. We&#13;
may expect that the transplant for bone defects recovery that would satisfy the requirements of oncology can be developed.
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/13385</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
